Malvern has announced it will be hosting a webinar about the use of laser diffraction as a technique in characterising nebulisers and how it is helpful in understanding the delivery of the drug product.
The presentation will also cover the application of automated imaging technology in achieving orally inhaled and nasal drug product (OINDP) bioequivalence and how this technique is complementary to laser diffraction. In addition, there will be a case study highlighting the use of these two technologies in characterising Pulmicort respules as a nebuliser formulation.
The webinar will take place on 31 January from 12:00GMT to 13:00GMT.
Speaker Tamal Mukherjee has worked for Malvern Instruments’ Indian distributor Aimil for ten years. His initial role was as an applications specialist with Aimil, moving in 2012 to a product technical specialist role with responsibility for Malvern’s laser diffraction and analytical imaging technologies.
Tamal now manages Malvern’s key accounts in India. Throughout his career with Malvern Aimil, Tamal has worked closely with the top generics companies in India, helping them resolve issues with particle characterisation applications, method development, and validation, as well as learning about regulatory requirements and issues with generic drug development. He is particularly interested in the development of generic drugs in the OINDP sector.
Who should attend?
Researchers engaged in product deformulation for OINDPs, primarily nebulisers, will be interested in the webinar, along with formulation developers producing generic pharmaceutical products and scientists engaged in applying in-vitro techniques for Bioequivalence studies.
What will you learn?
The webinar will cover the usefulness of laser diffraction for spray characterisation, the use of automated imaging analysis in achieving OINDP bioequivalence, and a demonstration of the above technologies in a nebuliser development case study.
